Working Group Meetings
SCCS WG meeting on nanomaterials in cosmetic products – June 2022
On 9 June 2022, the SCCS meeting of the Working Group (WG) on nanomaterials in cosmetic products was held.
On average, 70% of our news is listed, while updates from the last 30 days are not visible.
To get access to all content and services,
Start your Free Trial or Discover our plans.
Already a Premium member? Sign In
On 9 June 2022, the SCCS meeting of the Working Group (WG) on nanomaterials in cosmetic products was held.
Although it is easy to identify some Aluminium (AL)-cosmetic ingredients by their INCI name containing the word “Aluminum”, there are many Al-containing ingredients difficult to be identified.
The draft agenda of the Scientific Committee on Consumer Safety (SCCS) 2nd plenary meeting, on 21-22 June 2022, has just been published.
On 31 May and 1 June 2022, the SCCS meeting of the Working Group (WG) on cosmetic ingredients in cosmetic products was held.
The Scientific Committee has published the preliminary opinion on Aluminium (Al) in cosmetic products after the European Commission’s request to demonstrate the safe use of Aluminium in product categories other than deodorants, antiperspirants, lipsticks, and toothpaste, considering also the aggregate exposure. The SCCS adopted this document by written procedure on Read more…
The Scientific Committee has published its final Opinion on 4-Methylbenzylidene camphor (4-MBC). It was adopted by written procedure on 29 April 2022.
On 29 April 2022, the SCCS meeting of the Working Group (WG) on nanomaterials in cosmetic products was held.
On 5 April 2022, the European Commission started a consultation inviting any interested parties to submit data aiming to identify the various salicylic esters used in cosmetic products that are metabolised to Salicylic Acid. This will help SCCS to proceed with an assessment of the aggregate exposure to Salicylic Acid Read more…
On 19-20 April 2022, the SCCS meeting of the Working Group (WG) on cosmetic ingredients in cosmetic products was held.
Considering the concerns related to potential endocrine-disrupting properties of “Salicylic Acid” the European Commission has asked the Scientific Committee to assess its safety in cosmetic products. On 3 February 2022, this mandate has been accepted by the SCCS and the Committee has nine months to deliver its Opinion.